Quantitative Molecular Microscopy

Credit: COURTESY OF MARISA DOLLED-FILHAST, HISTO Rx" /> Credit: COURTESY OF MARISA DOLLED-FILHAST, HISTO Rx Traditional histopathology analysis has two basic problems. First, it isn't granular enough: Pathologists typically grade overall marker-staining intensity using a four-point scale. The other problem is that these measurements don't account for the sometimes-subtle changes in subcellular localization that can indicate disease. Beta-catenin, for instance, is a biomarker for colon can

Written byJeffrey M. Perkel
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Traditional histopathology analysis has two basic problems. First, it isn't granular enough: Pathologists typically grade overall marker-staining intensity using a four-point scale. The other problem is that these measurements don't account for the sometimes-subtle changes in subcellular localization that can indicate disease. Beta-catenin, for instance, is a biomarker for colon cancer, but only when localized to the nucleus. Yale University pathologists Bob Camp and David Rimm developed a series of algorithms called AQUA (Automated Quantitative Analysis) to overcome these shortcomings, providing compartment-specific staining-intensity data over the range of 0 to 255, which has been shown to be directly proportional to absolute protein concentrations.

In this example, estrogen receptor staining is being quantified in cancerous breast tissue. The cells are stained with three tags: cytokeratin (green, A), which differentiates the tumor from surrounding tissue; DAPI (blue, B), which stains nuclei; and an anti-estrogen (ER) receptor antibody (red, C).

Cytokeratin staining is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies